CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+6.6%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$729M
AUM Growth
+$729M
(+8.4%)
Cap. Flow
+$68.4M
Cap. Flow
% of AUM
9.39%
Top 10 Holdings %
Top 10 Hldgs %
68%
Holding
32
New
8
Increased
10
Reduced
8
Closed
6
Top Buys
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$44.6M |
| 2 |
United Therapeutics
UTHR
|
$43.1M |
| 3 |
AKRX
Akorn, Inc.
AKRX
|
$24M |
| 4 |
RLYP
RELYPSA INC COM
RLYP
|
$13.9M |
| 5 |
Travere Therapeutics
TVTX
|
$13.9M |
Top Sells
| 1 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
$37.6M |
| 2 |
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
|
$25.3M |
| 3 |
Myriad Genetics
MYGN
|
$19.8M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
$15.8M |
| 5 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$10.3M |
Sector Composition
| 1 | Healthcare | 69.06% |
| 2 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $98M | 13.45% | 761,762 +334,972 | +78% | +$43.1M |
|
2
Enanta Pharmaceuticals
ENTA
$180M
| $63.3M | 8.68% | 1,599,109 +53,012 | +3% | +$2.1M |
|
|
TARO
3
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $47.9M | 6.57% | 311,234 -67,138 | -18% | -$10.3M |
|
|
CSII
4
DELISTED
Cardiovascular Systems, Inc.
CSII
| $45.9M | 6.3% | 1,943,054 +317,934 | +20% | +$7.51M |
|
|
AUXL
5
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $44.6M | 6.12% | +1,493,560 | New | +$44.6M |
|
6
Orthofix Medical
OFIX
$592M
| $44.5M | 6.1% | 1,436,495 -34,658 | -2% | -$1.07M |
|
|
INSY
7
DELISTED
Insys Therapeutics, Inc.
INSY
| $43.4M | 5.96% | 1,119,917 -68,399 | -6% | -$2.65M |
|
|
AKRX
8
DELISTED
Akorn, Inc.
AKRX
| $42.6M | 5.84% | 1,173,485 +661,400 | +129% | +$24M |
|
9
AbbVie
ABBV
$372B
| $33.4M | 4.59% | 579,100 -32,200 | -5% | -$1.86M |
|
|
HPTX
10
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $31.9M | 4.37% | 1,263,034 -16,014 | -1% | -$404K |
|
|
PTX
11
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $26.4M | 3.63% | 3,443,137 +418,286 | +14% | +$3.21M |
|
|
ANAC
12
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $25.4M | 3.49% | 1,038,553 +150,347 | +17% | +$3.68M |
|
13
Option Care Health
OPCH
$4.65B
| $21.8M | 2.99% | 3,153,952 -796,887 | -20% | -$5.51M |
|
|
HMSY
14
DELISTED
HMS Holdings Corp.
HMSY
| $21.2M | 2.91% | 1,123,126 +25,000 | +2% | +$471K |
|
|
OSIR
15
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $19.9M | 2.73% | 1,579,561 -390,500 | -20% | -$4.92M |
|
16
ANI Pharmaceuticals
ANIP
$2.03B
| $15.5M | 2.13% | 549,827 +194,551 | +55% | +$5.5M |
|
|
RLYP
17
DELISTED
RELYPSA INC COM
RLYP
| $13.9M | 1.91% | +660,462 | New | +$13.9M |
|
|
18
Travere Therapeutics
TVTX
$1.56B
| $13.9M | 1.91% | +1,539,459 | New | +$13.9M |
|
|
MACK
19
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $13.5M | 1.85% | +1,536,902 | New | +$13.5M |
|
|
DSCI
20
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $12.7M | 1.74% | 1,520,404 +68,712 | +5% | +$572K |
|
21
Protalix BioTherapeutics
PLX
$124M
| $12.2M | 1.67% | +5,027,338 | New | +$12.2M |
|
|
TVTY
22
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $11.2M | 1.54% | 698,190 -151,812 | -18% | -$2.43M |
|
23
ADMA Biologics
ADMA
$4.12B
| $8M | 1.1% | 776,863 +109,764 | +16% | +$1.13M |
|
24
Vericel Corp
VCEL
$1.83B
| $6.71M | 0.92% | +2,352,940 | New | +$6.71M |
|
|
TLGT
25
DELISTED
Teligent, Inc
TLGT
| $6.7M | 0.92% | +719,278 | New | +$6.7M |
|